Results 151 to 160 of about 9,825 (225)
Modified vaccinia virus Ankara (MVA) is a promising orthopoxvirus (OPXV) vector vaccine candidate due to its host range restriction and good safety profile as a smallpox vaccine. It has been widely tested in clinical trials as a recombinant vector for vaccination against infectious diseases and cancers in humans and animals.
openaire +1 more source
Efficacy of Multiple- or Single-Dose Cidofovir against Vaccinia and Cowpox Virus Infections in Mice
Debra C. Quenelle+2 more
openalex +1 more source
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir
Debra C. Quenelle+2 more
openalex +1 more source
Degradation of Cowpox Virus in HVJ (Sendai Virus) Carrier Cells [PDF]
Hisashi Ogura+9 more
openaire +3 more sources
Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus. [PDF]
Diaz-Cánova D+4 more
europepmc +1 more source
Cowpox virus infection in two brothers with possible human‐to‐human transmission [PDF]
Giedrė Tamulytė+4 more
openalex +1 more source
Epidemiological Investigations of Four Cowpox Virus Outbreaks in Alpaca Herds, Germany. [PDF]
Prkno A+12 more
europepmc +1 more source
Novel characteristics identified in two cases of feline cowpox virus infection. [PDF]
Breheny CR+11 more
europepmc +1 more source